Melanie Pickett, MD
Dermatology · Austin, TXNPI 1407274996
Payments from drug & device makers
Across 462 payments — averaging $19.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$988
- Almirall LLC$945
- Sanofi$643
- UCB, Inc.$615
- Mayne Pharma Commercial LLC$605
- AbbVie$582
- plus $4K from 28 others
What the payments were for
- Consulting fees$8009%
- Food & beverage$7,78189%
- Education$1992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 73 | $988 |
| Almirall LLC | 3 | $945 |
| Sanofi | 27 | $643 |
| UCB, Inc. | 31 | $615 |
| Mayne Pharma Commercial LLC | 51 | $605 |
| AbbVie | 19 | $582 |
| Galderma Laboratories, L.p. | 26 | $504 |
| VYNE Pharmaceuticals Inc. | 30 | $458 |
| Sun Pharmaceutical Industries Inc. | 19 | $357 |
| Novartis | 18 | $346 |
| LEO Pharma Inc. | 17 | $335 |
| E.r. Squibb & Sons, L.L.C. | 34 | $297 |
| Arcutis Biotherapeutics, Inc. | 13 | $261 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 16 | $258 |
| Lilly USA, LLC | 14 | $256 |
| Amgen | 10 | $233 |
| Pfizer | 13 | $214 |
| Regeneron Healthcare Solutions, Inc. | 11 | $211 |
| Incyte Corporation | 4 | $90 |
| EPI Health, LLC | 4 | $90 |
| Aclaris Therapeutics, Inc. | 5 | $75 |
| Organon | 6 | $72 |
| Dermavant Sciences, Inc. | 4 | $71 |
| Dermira, Inc. | 3 | $52 |
| Convatec Inc. | 1 | $33 |
| Kerecis Limited | 1 | $31 |
| Biofrontera Inc. | 2 | $30 |
| Mimedx Group, Inc. | 1 | $28 |
| Mission Pharmacal Company | 1 | $22 |
| Bristol Myers Squibb | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $17 |
| Botanix SB Inc | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,780 in reported general payments places this provider in the 65th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $94,701 |
| Taltz AutoinjectorIxekizumab | 11 | $78,355 |
| Ketoconazole | 46 | $872 |
| Fluorouracil | 11 | $717 |
| Clobetasol Propionate | 22 | $663 |
| Ciclopirox | 22 | $540 |
| Fluocinonide | 12 | $435 |
| Triamcinolone Acetonide | 36 | $266 |
| Spironolactone | 28 | $255 |
| Doxycycline Hyclate | 11 | $187 |
| Hydrocortisone | 20 | $186 |
| Mupirocin | 15 | $90 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Austin
- Edward LainAustin$12M
- Janet DuboisAustin$3.5M
- Daniel CarrascoAustin$1.4M
- Dale SchaeferAustin$1M
- Heidi PratherAustin$543K
- Ali ShahbazAustin$413K
- David BushoreAustin$385K
- Blakely RichardsonAustin$279K
- Stephen TyringWebster$14.1M
- Mark LeeSan Antonio$10.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.